DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Indef Manufacturing Q2 FY27: Date and Outlook

Univest 21 hrs ago·9 Sept 2026, 11:12 am

Indef Manufacturing has announced the schedule for its Q2 FY27 results, marking a key update for investors. The company will release its financial data for the quarter, providing a snapshot of its recent operational and financial performance. This release is a routine but important event for shareholders to track the company's progress.

The outcome of this earnings report will be closely watched to gauge the company's current business momentum and future trajectory. Investors will be looking for clarity on operational efficiency and financial health. This information is crucial for assessing the company's standing in its sector.

Going forward, market participants should focus on the management's commentary regarding future strategy and market conditions. Any guidance provided will be vital for understanding the company's long-term prospects and potential risks.